1887

Journal of General Virology header logo

Volume 86, Issue 7

Deletion of open reading frames 9, 10 and 11 from the avian adenovirus CELO genome: effect on biodistribution and humoral responses Free

Abstract

In this study, the effect of the 3·6 kbp deletion of the three open reading frames (ORF) 9, 10 and 11 found at the right end of the CELO genome was examined. Groups of chickens were inoculated oronasally with 10–10 p.f.u. per animal of wild-type virus and two recombinant CELO strains (rCELO) expressing luciferase and secreted alkaline phosphatase (SEAP). The tissue biodistribution, assessed by PCR, was similar for both wild-type and recombinant viruses. The infectious viral particle titre was determined by a p.f.u. counting method and the antibody responses to the CELO vector and the SEAP antigen were evaluated by ELISA. Infectious particle titres in tissues from chickens inoculated with the wild-type CELO virus increased up to 6 days post-inoculation, and declined until 11 days while titres in organs from chickens inoculated with the rCELO strain were low and only detectable at 4 days post-inoculation. Moreover, although anti-CELO antibody levels were three times lower in sera from chickens inoculated with rCELO, antibodies directed to the heterologous SEAP antigen were detected. Based on these results, no differences in tropism were observed, but the level of production of viral particles and the humoral responses appeared to decrease. Viruses replicate less efficiently with a deletion performed at the right end of the CELO genome. Nevertheless, the presence of antibodies directed to heterologous antigens makes the CELO virus an advantageous candidate for avian vaccination.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80879-0
2005-07-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/7/vir862019.html?itemId=/content/journal/jgv/10.1099/vir.0.80879-0&mimeType=html&fmt=ahah

References

  1. Benihoud K., Yeh P., Perricaudet M. 1999; Adenovirus vectors for gene delivery. Curr Opin Biotechnol 10:440–447 [CrossRef]
     [Google Scholar]
  2. Brandt C. D., Kim H. W., Yolken R. H., Kapikian A. Z., Arrobio J. O., Rodriguez W. J., Wyatt R. G., Chanock R. M., Parrott R. H. 1979; Comparative epidemiology of two rotavirus serotypes and other viral agents associated with pediatric gastroenteritis. Am J Epidemiol 110:243–254
     [Google Scholar]
  3. Brown M. D., Green P., Skinner M. A. 1994; VP2 sequences of recent European ‘very virulent’ isolates of infectious bursal disease virus are closely related to each other but are distinct from those of ‘classical’ strains. J Gen Virol 75:675–680 [CrossRef]
     [Google Scholar]
  4. Chiocca S., Kurzbauer R., Schaffner G., Baker A., Mautner V., Cotten M. 1996; The complete DNA sequence and genomic organization of the avian adenovirus CELO. J Virol 70:2939–2949
     [Google Scholar]
  5. Chiocca S., Baker A., Cotten M. 1997; Identification of a novel antiapoptotic protein, GAM-1, encoded by the CELO adenovirus. J Virol 71:3168–3177
     [Google Scholar]
  6. Cowen B., Calnek B. W., Menendez N. A., Ball R. F. 1978; Avian adenoviruses: effect on egg production, shell quality, and feed consumption. Avian Dis 22:459–470 [CrossRef]
     [Google Scholar]
  7. Deryckere F., Burgert H. G. 1996; Early region 3 of adenovirus type 19 (subgroup D) encodes an HLA-binding protein distinct from that of subgroups B and C. J Virol 70:2832–2841
     [Google Scholar]
  8. Favier A. L., Schoehn G., Jaquinod M., Harsi C., Chroboczek J. 2002; Structural studies of human enteric adenovirus type 41. Virology 293:75–85 [CrossRef]
     [Google Scholar]
  9. Favier A. L., Burmeister W. P., Chroboczek J. 2004; Unique physicochemical properties of human enteric Ad41 responsible for its survival and replication in the gastrointestinal tract. Virology 322:93–104 [CrossRef]
     [Google Scholar]
  10. Francois A., Eterradossi N., Delmas B., Payet V., Langlois P. 2001; Construction of avian adenovirus CELO recombinants in cosmids. J Virol 75:5288–5301 [CrossRef]
     [Google Scholar]
  11. Francois A., Chevalier C., Delmas B., Eterradossi N., Toquin D., Rivallan G., Langlois P. 2004; Avian adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens. Vaccine 22:2351–2360 [CrossRef]
     [Google Scholar]
  12. Graham F. L. 1990; Adenoviruses as expression vectors and recombinant vaccines. Trends Biotechnol 8:85–87 [CrossRef]
     [Google Scholar]
  13. Graham F. L., Prevec L. 1995; Methods for construction of adenovirus vectors. Mol Biotechnol 3:207–220 [CrossRef]
     [Google Scholar]
  14. Hammond J. M., McCoy R. J., Jansen E. S., Morrissy C. J., Hodgson A. L., Johnson M. A. 2000; Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever. Vaccine 18:1040–1050 [CrossRef]
     [Google Scholar]
  15. Hitt M. M., Addison C. L., Graham F. L. 1997; Human adenovirus vectors for gene transfer into mammalian cells. Adv Pharmacol 40:137–206
     [Google Scholar]
  16. Horwitz M. S. 1996; Adenoviridae , the viruses and their replication. In Fields Virology Edited by Knipe D. M., Fields B. N., Howley P. M. et al. Philadelphia, PA: Lippincott-Raven;
     [Google Scholar]
  17. Kesik M., Saczynska V., Szewczyk B., Plucienniczak A. 2004; Inclusion bodies from recombinant bacteria as a novel system for delivery of vaccine antigen by the oral route. Immunol Lett 91:197–204 [CrossRef]
     [Google Scholar]
  18. Klonjkowski B., Gilardi-Hebenstreit P., Hadchouel J., Randrianarison V., Boutin S., Yeh P., Perricaudet M., Kremer E. J. 1997; A recombinant E1-deleted canine adenoviral vector capable of transduction and expression of a transgene in human-derived cells and in vivo. Hum Gene Ther 8:2103–2115 [CrossRef]
     [Google Scholar]
  19. Laver W. G., Younghusband H. B., Wrigley N. G. 1971; Purification and properties of chick embryo lethal orphan virus (an avian adenovirus). Virology 45:598–614 [CrossRef]
     [Google Scholar]
  20. Le Goff F., Mederle I., Girard-Misguich F., Langlois P. 2003; Preliminary data of adenovirus CELO localisation in chicken. Br Poult Sci 44:823–824 [CrossRef]
     [Google Scholar]
  21. Lehrmann H., Cotten M. 1999; Characterization of CELO virus proteins that modulate the pRb/E2F pathway. J Virol 73:6517–6525
     [Google Scholar]
  22. Lemay P., Boudin M. L., Milleville M., Boulanger P. 1980; Human adenovirus type 2 protein IIIa. I. Purification and characterization. Virology 101:131–143 [CrossRef]
     [Google Scholar]
  23. Lewis P. J., Babiuk L. A. 1999; DNA vaccines: a review. Adv Virus Res 54:129–188
     [Google Scholar]
  24. Lo R. Y. 1987; The development of subunit and synthetic vaccines using recombinant DNA technology. Biotechnol Adv 5:235–256 [CrossRef]
     [Google Scholar]
  25. Maiti N. K., Sarkar P. 1997; Humoral immune response of chicks to different clinical isolates of avian adenovirus type-1. Comp Immunol Microbiol Infect Dis 20:59–62 [CrossRef]
     [Google Scholar]
  26. Michou A. I., Lehrmann H., Saltik M., Cotten M. 1999; Mutational analysis of the avian adenovirus CELO, which provides a basis for gene delivery vectors. J Virol 73:1399–1410
     [Google Scholar]
  27. Nakamura T., Sato K., Hamada H. 2003; Reduction of natural adenovirus tropism to the liver by both ablation of fiber-coxsackievirus and adenovirus receptor interaction and use of replaceable short fiber. J Virol 77:2512–2521 [CrossRef]
     [Google Scholar]
  28. Ojkic D., Nagy E. 2003; Antibody response and virus tissue distribution in chickens inoculated with wild-type and recombinant fowl adenoviruses. Vaccine 22:42–48 [CrossRef]
     [Google Scholar]
  29. Paillard F. 1997; Advantages of non-human adenoviruses versus human adenoviruses. Hum Gene Ther 8:2007–2009 [CrossRef]
     [Google Scholar]
  30. Payet V., Arnauld C., Picault J. P., Jestin A., Langlois P. 1998; Transcriptional organization of the avian adenovirus CELO. J Virol 72:9278–9285
     [Google Scholar]
  31. Rasmussen U. B., Benchaibi M., Meyer V., Schlesinger Y., Schughart K. 1999; Novel human gene transfer vectors: evaluation of wild-type and recombinant animal adenoviruses in human-derived cells. Hum Gene Ther 10:2587–2599 [CrossRef]
     [Google Scholar]
  32. Reddy P. S., Idamakanti N., Hyun B. H., Tikoo S. K., Babiuk L. A. 1999; Development of porcine adenovirus-3 as an expression vector. J Gen Virol 80:563–570
     [Google Scholar]
  33. Rekosh D. M., Russell W. C., Bellet A. J., Robinson A. J. 1977; Identification of a protein linked to the ends of adenovirus DNA. Cell 11:283–295 [CrossRef]
     [Google Scholar]
  34. Sheppard M. 1999; Viral vectors for veterinary vaccines. Adv Vet Med 41:145–161
     [Google Scholar]
  35. Stewart P. L., Fuller S. D., Burnett R. M. 1993; Difference imaging of adenovirus: bridging the resolution gap between X-ray crystallography and electron microscopy. EMBO J 12:2589–2599
     [Google Scholar]
  36. Uhnoo I., Wadell G., Svensson L., Johansson M. E. 1984; Importance of enteric adenoviruses 40 and 41 in acute gastroenteritis in infants and young children. J Clin Microbiol 20:365–372
     [Google Scholar]
  37. Washietl S., Eisenhaber F. 2003; Reannotation of the CELO genome characterizes a set of previously unassigned open reading frames and points to novel modes of host interaction in avian adenoviruses. BMC Bioinformatics 4:55 [CrossRef]
     [Google Scholar]
  38. Williams A. F., Barclay A. N. 1988; The immunoglobulin superfamily – domains for cell surface recognition. Annu Rev Immunol 6:381–405 [CrossRef]
     [Google Scholar]
  39. Windheim M., Burgert H. G. 2002; Characterization of E3/49K, a novel, highly glycosylated E3 protein of the epidemic keratoconjunctivitis-causing adenovirus type 19a. J Virol 76:755–766 [CrossRef]
     [Google Scholar]
  40. Yang Y., Ertl H. C., Wilson J. M. 1994; MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1:433–442 [CrossRef]
     [Google Scholar]
  41. Yang Y., Xiang Z., Ertl H. C., Wilson J. M. 1995; Upregulation of class I major histocompatibility complex antigens by interferon γ is necessary for T-cell-mediated elimination of recombinant adenovirus-infected hepatocytes in vivo. Proc Natl Acad Sci U S A 92:7257–7261 [CrossRef]
     [Google Scholar]
  42. Zhang W. W. 1999; Development and application of adenoviral vectors for gene therapy of cancer. Cancer Gene Ther 6:113–138 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80879-0
Loading
Deletion of open reading frames 9, 10 and 11 from the avian adenovirus CELO genome: effect on biodistribution and humoral responses
J. Gen. Virol. 86, 2019 (2005); https://doi.org/10.1099/vir.0.80879-0
/content/journal/jgv/10.1099/vir.0.80879-0
/content/journal/jgv/10.1099/vir.0.80879-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error